Panakès Partners is a venture capital firm that specializes in investments in the healthcare sector, focusing on medical technologies, biotechnology, and digital health. The firm aims to support innovative startups and early-stage companies with the potential to significantly impact the healthcare industry through their cutting-edge solutions.

Diana Saraceni

Fabrizio Landi

Alessio Beverina

Panakès Partners

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

MedTech World is a global event management company that organizes an annual investor and entrepreneur conference in the medtech and health tech sector in Malta, along with multiple roadshow events worldwide. It fosters collaboration among stakeholders to enhance healthcare.

MedTech World

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management.Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our founders in accelerating their development.We invest in people, believing that a strong and dedicated team is one of the most important factors in the success of our investments. We aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor.We invest for people, supporting the growth of companies and people that will reshape the medical world, answering real medical needs, saving lives and providing a better quality of life for patients and care-givers.An overall positive impact that will produce intrinsic value for both investors and society. Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick.

Metric
Company Name	Panakès Partners	Medical Devices Venture	MedTech World
Symbol
MSH ID	IT:PANAKES	COM:MEDICALDEVICESVENTURE	WORLD:MED-TECH
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services
Industry	Healthcare	Medical Devices	Event Management
Country	IT	FR	MT
Stage
Employee Count	16
Website	panakes.it	medicaldevicesventure.com	med-tech.world
LinkedIn	panakes-partners	medical-devices-venture	mtw-medtech-world
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	405
Web Traffic Growth	-0.67
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

IT:PANAKES

Panakès Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue